Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

STRIDES PHARMA SCIENCE LTD.

NSE : STARBSE : 532531ISIN CODE : INE939A01011Industry : Pharmaceuticals & DrugsHouse : Private

BSE969.753.95 (+0.41 %)

PREV CLOSE ( ) 965.80

OPEN PRICE ( ) 936.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 6546

TODAY'S LOW / HIGH ( )925.00 974.90

52 WK LOW / HIGH ( )551 1024.9

NSE971.157.55 (+0.78 %)

PREV CLOSE( ) 963.60

OPEN PRICE ( ) 958.80

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 971.15 (141)

VOLUME 212162

TODAY'S LOW / HIGH( ) 925.00 974.80

52 WK LOW / HIGH ( )513.05 1025

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 28-06 1990

Management Info

Arun Kumar - Chairman Badree Komandur - Managing Director

Registered Office

Address Cyberone, Unit No. 902,Plot No - 4 & 6,Sector 30 A, Vashi,
Navi Mumbai,
Maharashtra-400703

Phone 022-27892924 / 3199

Email corpcomm@strides.com

Website www.strides.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

18Mar Strides Pharma's arm inks pact with Sa
Strides Pharma Science’s step-down subsidiary -- Strides Pharma Internat..

18Mar Strides Pharma surges as its arm inks
Strides Pharma Science is currently trading at Rs. 903.40, up by 27.15 p..

18Feb Strides Pharma moves up as its arm acq
Strides Pharma Science is currently trading at Rs. 885.20, up by 4.65 po..

17Feb Strides Pharma’s arm acquires Neviton
Strides Pharma Science’s wholly owned subsidiary -- Arco Lab has complet..

05Feb Strides Pharma Science informs about
Strides Pharma Science has informed that it enclosed Press Release issue..

Financials

Rs. in Millions

	QTR Dec 25	ANNUAL 25
Net Profit	1218.95	28862.11
Gross Profit	1348.02	780.829999999999
Operating Profit	1844.42	3086.3
Net Sales	5536.32	21394.23

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE) 2146.70 (3.09%)	M.Cap ( in Cr)1326.24
Hester Biosciences (BSE) 1427.90 (4.01%)	M.Cap ( in Cr)1214.70
Haleos Labs (BSE) 1299.00 (3.61%)	M.Cap ( in Cr)392.72
RPG Life Sciences (BSE) 1922.95 (2.35%)	M.Cap ( in Cr)3180.37
Albert David (BSE) 653.15 (6.34%)	M.Cap ( in Cr)372.76

Shareholding Pattern

	NON-INSTITUTION	29.59%
	PROMOTERS	27.86%
	MUTUAL FUNDS/UTI	8.59%
	FI/BANKS/INSURANCE	3.06%
	GOVERNMENT	0.01%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Quant Business Cycl...	1.44
JM Small Cap Fund-Reg(G)	1.30
Quant Multi Cap Fund(G)	1.26
WOC Pharma and Heal...	1.10
ITI Pharma & Health...	1.08
Quant Small Cap Fund(G)	1.01
Aditya Birla SL Val...	0.84

Risk Disclosures on Derivatives

Smart Quotes

STRIDES PHARMA SCIENCE LTD.